To date, 2016 was without a doubt the most successful year for the cannabis industry, and it’s only going to continue flourishing.
As such, the Investing News Network (INN) covered a number of the year’s biggest cannabis news stories–ranging from top stocks, legalization in the US and the release of the Task force in Canada.
With an abundance of cannabis news stories, investors were more interested in the sector than ever.
Read on to see what five top cannabis news stories 2016 caught the attention of our investor audience.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

1. 19 Canadian Marijuana Stocks

First on the top cannabis news stories 2016 is a look at 19 Canadian marijuana stocks. At the time, the Canadian government’s task force on legalization of marijuana hadn’t been released, but cannabis stocks were still soaring. In the summer of 2016, Predictive Index analyst Jason Zandberg put forth the prediction that the cannabis market would be worth $4.9 billion by 2019, and climbing to $7.4 billion within the first five years of legalization.
Bearing that in mind, it’s no wonder investors were keen to read about cannabis stocks already listed on Canadian exchanges, including Canopy Growth (TSX:CGC), Mettrum (TSXV:MT), OrganiGram (TSXV:OGI), Aurora Cannabis (TSXV:ACB), THC Biomed (CSE:THC), among others.


2. 10 Top Canadian Cannabis Stocks

As it can be seen, Canadian cannabis stocks were a hot read in 2016. While the former focus on a variety of Canadian marijuana stocks, this one looks at the 10 top performing stocks year-to-date (as of October).
With the help from a list compiled by CanTech Letter, INN dove in with some additional information about the companies listed–some of which were mentioned above–including, Maple Leaf Green World (TSXV:MGW), Emerald Health Therapeutics (TSXV:EMH), and Cannabix Technologies (CSNX:BLO).

3. How to Find the Best Cannabis Stocks to Invest in

Keeping with the cannabis stocks theme, our audience was keen to learn how to find the best cannabis stocks to invest in. Like the previous two articles, this one had been done before legalization in Canada and the US (at a federal level) was in play. In the article, former Wall Street attorney Chris Milenkevich talks with INN about what investors should look for when stepping into the cannabis stocks sector.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

4. Cannabis Outlook 2017: Legalization on the Horizon

Taking the above three articles into consideration, it should come as no surprise that looking ahead, investors were eager to look at what’s in store in the coming year. With legalization in Canada ready to launch in the spring, INN had the chance to speak with 420 Investor Alan Brochstein to talk about how the cannabis industry is shaping up this year.

5. Why Aurora’s Expansion is Significant to the Cannabis Industry

Rounding out the list of top cannabis news stories 2016 is an interview INN did later in the year with vice president of Aurora Cannabis, Cam Battley. In November, the company announced that it had begun construction on an 80,000 square foot expansion, called “Aurora Sky.” When completed, it is projected to  be the largest cannabis production facility in the world.
In the interview, Battley discusses how the facility will set Aurora apart from other cannabis companies, why they chose Dutch design for the expansion, and how the legalization of recreational marijuana will impact the facility.
 
Don’t forget to follow us @INN_Resource for real-time news updates.
Securities Disclosure: I, Jocelyn Aspa, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Mettrum Health is a client of the Investing News Network. This article is not paid for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.

Keep reading... Show less

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less

New findings suggest the COVID-19 pandemic, combined with expanded state legalization, has attracted new consumers to the category and accelerated cannabis acceptance and adoption.

  • YouGov study indicates the number of current cannabis consumers has increased 56% within just two years compared to the 16% of Americans who reported current consumption in 2018.
  • 23% of current consumers say they tried cannabis for the first time within the past year.
  • More than half of cannabis consumers say they will purchase or try a new product or format this 420, indicating that the holiday is becoming increasingly focused on exploration and trial.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, released the results of a survey today showing one in four Americans currently consume cannabis, reporting they’ve tried some form of cannabis within the past twelve months. That’s a significant increase since 2018* when just 16% of U.S. adults reported current consumption, representing a 56% increase in just two years. What’s more, 23% of current cannabis consumers say they tried cannabis for the first time over the past year, suggesting the COVID-19 pandemic, combined with expanded state legalization, has rapidly accelerated cannabis acceptance and adoption in America.

Keep reading... Show less

Acquires Three Operating Dispensaries in Northeast Pennsylvania

Purchase price represents a mid-single digit multiple of KCR’s expected 2021 EBITDA

Keep reading... Show less